Real‐World Assessment of Trilaciclib for the Prevention of Chemoradiotherapy‐Induced Myelosuppression in Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
Trilaciclib prevented myelosuppression in patients with esophageal cancer undergoing concurrent chemoradiotherapy, demonstrating good safety and efficacy.
Authors
- Hui Chen (ORCID: https://orcid.org/0000-0003-2866-7811)
- Junrong Yan (ORCID: https://orcid.org/0000-0001-9750-7518)
- Xiaojie Xia
- Xinchen Sun (ORCID: https://orcid.org/0000-0003-2752-9687)
- Zeyuan Liu (ORCID: https://orcid.org/0000-0002-5627-2094)
- Xiaolin Ge
Institutions
- Jiangsu Province Hospital (CN)
- Nanjing Jiangning Hospital (CN)
- Kangda College of Nanjing Medical University
- Nanjing Medical University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/cam4.70862
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Nanjing Medical University